The Effect of Verapamil on TXNIP Gene Expression, GLP1R mRNA, FBS, HbA1c, and Lipid Profile in T2DM Patients Receiving Metformin and Sitagliptin.

Malayeri, Alireza; Zakerkish, Mehrnoosh; Ramesh, Farrokh; Galehdari, Hamid; Hemmati, Ali Asghar; Angali, Kambiz A

Malayeri, Alireza; Zakerkish, Mehrnoosh; Ramesh, Farrokh; Galehdari, Hamid; Hemmati, Ali Asghar; Angali, Kambiz A.

Afiliación

Malayeri A; Department of Pharmacology, School of Pharmacy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Zakerkish M; Department of Internal Medicine, Diabetes Research Centre, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. zakerkish-m@ajums.ac.ir.
Ramesh F; Department of Pharmacology, School of Pharmacy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Galehdari H; Department of Genetics, Faculty of Sciences, Shahid Chamran University of Ahvaz, Ahvaz, Iran.
Hemmati AA; Medicinal Plant Research Center, School of Pharmacy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Angali KA; Department of Biostatistics and Epidemiology, School of Health, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.

Diabetes Ther ; 12(10): 2701-2713, 2021 Oct.

Article en En | MEDLINE | ID: mdl-34480721

Palabras clave

Randomized controlled trials; TXNIP; Type 2 diabetes; Verapamil

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Observational_studies / Risk_factors_studies Idioma: En Revista: Diabetes Ther Año: 2021 Tipo del documento: Article País de afiliación: Irán Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google